Amerigen announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Carbidopa 25mg Tablets, the generic version of Valeant’s Lodosyn. Carbidopa is dopa-decarboxylase inhibitor indicated for the treatment of symptoms of Parkinson’s disease in combination with carbidopa-levodopa (Sinemet) or with levodopa alone.
Administration of carbidopa with levodopa makes more levodopa available for transport to the brain. As it crosses the blood-brain barrier, it is presumably is converted to dopamine in the brain. This is thought to be the mechanism whereby levodopa relieves symptoms of Parkinson’s disease.
Carbidopa 25mg Tablets are now available for shipping.
For more information call (732) 993-9827 or visit Amerigenpharma.com.